Detalles de la búsqueda
1.
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Ann Oncol
; 34(8): 645-659, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269905
2.
The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition.
Ann Oncol
; 32(10): 1236-1244, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34311075
3.
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project.
Ann Oncol
; 32(12): 1626-1636, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606929
4.
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study.
Ann Oncol
; 31(5): 569-581, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32278621
5.
A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design.
Semin Cancer Biol
; 52(Pt 2): 158-165, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29307568
6.
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.
Semin Cancer Biol
; 52(Pt 2): 151-157, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29990622
7.
Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?
Ann Oncol
; 35(5): 409-411, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484973
8.
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy.
Ann Oncol
; 30(12): 1941-1949, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31566659
9.
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
Ann Oncol
; 30(2): 236-242, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30590484
10.
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636].
Ann Oncol
; 35(1): 145, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558578
11.
Equine blastocyst production under different incubation temperatures and different CO2 concentrations during early cleavage.
Reprod Fertil Dev
; 31(12): 1823-1829, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31640846
12.
Lower blastocyst quality after conventional vs. Piezo ICSI in the horse reflects delayed sperm component remodeling and oocyte activation.
J Assist Reprod Genet
; 35(5): 825-840, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29637506
13.
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
Ann Oncol
; 28(2): 321-328, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28426105
14.
Effect of oral administration of Tribulus terrestris extract on semen quality and body fat index of infertile men.
Andrologia
; 49(5)2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27401787
15.
Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: the pathologists' perspective.
Ann Oncol
; 32(11): 1316-1321, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34461263
16.
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.
Ann Oncol
; 27(10): 1860-6, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27672107
17.
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
Ann Oncol
; 26(2): 259-71, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25214542
18.
Aortic Dissection Limited to Abdominal Aorta: an Underrecognized Entity?
Acta Chir Belg
; 115(4): 293-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324032
19.
The AURORA initiative for metastatic breast cancer.
Br J Cancer
; 111(10): 1881-7, 2014 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25225904
20.
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.
Ann Oncol
; 25(8): 1544-50, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24608200